Hartford Great Health Corp. Reports Officer, Director Changes

Ticker: HFUS · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1482554

Hartford Great Health CORP. 8-K Filing Summary
FieldDetail
CompanyHartford Great Health CORP. (HFUS)
Form Type8-K
Filed DateMar 19, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.001, $13,300
Sentimentneutral

Sentiment: neutral

Topics: management-change, corporate-governance, officer-appointment

TL;DR

Hartford Great Health Corp. is shuffling its leadership team and executive compensation.

AI Summary

Hartford Great Health Corp. (formerly Photoamigo, Inc.) filed an 8-K on March 19, 2024, reporting changes effective March 18, 2024. The filing indicates a departure of directors or certain officers, the election of new directors, and the appointment of certain officers, along with details on compensatory arrangements for these officers. The company, incorporated in Nevada, is based in Rosemead, California.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: medium — Changes in directorship and officer appointments, especially without immediate detailed explanations, can introduce uncertainty regarding future company direction and stability.

Key Players & Entities

FAQ

What specific changes were made regarding directors and officers?

The 8-K filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, effective March 18, 2024.

Are there details on the new compensatory arrangements for the appointed officers?

Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure.

When was this 8-K report filed with the SEC?

The report was filed on March 19, 2024.

What was Hartford Great Health Corp. previously known as?

The company was formerly known as Photoamigo, Inc.

Where are Hartford Great Health Corp.'s principal executive offices located?

The principal executive offices are located at 8832 Glendon Way, Rosemead, California, 91770.

Filing Stats: 1,127 words · 5 min read · ~4 pages · Grade level 11.7 · Accepted 2024-03-19 06:04:39

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 HARTFORD GREAT HEALTH CORP. (Exact name of registrant as specified in its charter) Nevada 000-54439 51-0675116 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 8832 Glendon Way , Rosemead , California 91770 (Address of principal executive offices) (Zip Code) 626 - 321-1915 Registrant's telephone number, including area code N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.001 par value HFUS OTC Markets Group Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Chief Executive Officer On March 18, 2024, Ms. Rose Hong Wang, Chief Executive Officer of Hartford Great Health Corp. (the "Company"), tendered her resignation from such position effective April 1, 2024. Ms. Wang's notice of resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or procedures. Ms. Wang will not be entitled to any compensation, payments or benefits from the Company or affiliates in connection with her resignation. Chief Executive Officer Appointment Upon Ms. Wang's departure on April 1, 2024, the Company intends to appoint Mr. Sheng-Yih Chang as Chief Executive Officer. Mr. Chang has also tendered his resignation on March 18, 2024 from the position of Chief Financial Officer of the Company, to be effective on April 1, 2024. Mr. Chang has served as the Chief Financial Officer of the Company since June 2018, and the General Manager at Hartford Hotel, a commercial hotel in Rosemead California since March 2018. Mr. Chang served as a Product Manager at Jowett Group, a textile manufacturing company in the USA, from November 2015 through September 2017, as an Operational Manager and General Manager at A-Concepts Designs, a houseware supplier company in the USA, from January 2004 through October 2015, as a General Manager at Long Arch International, a carving crafts supplier in the USA, from December 2000 through December 2003, as a Sales Manager at EZ Wholesale, a general merchandise wholesaler in the USA, from July 1998 through November 2000, and as a technician at Richcom Computer Corporation, a computer service provider in California, from July 1996 through November 1997. Mr. Chang studied electrical engineering at the University of British Columbia and holds a Bachelor of Science in Electrical Engineering from California State University, Northridge. Appointment of Interim Chief Financial Officer In connection with Mr. Chang's resignation of Chief Financial Officer, on March 18, 2024, the Company entered into an interim CFO Consulting Agreement (the "Consulting Agreement") with Green-Keen Consulting LLC ("GKC"), pursuant to which the Company appointed Ms. Lili Dai as interim Chief Financial Officer, to be effective April 1, 2024, with a term ending March 31, 2025. Pursuant to the Consulting Agreement, the Company will pay GKC a fixed monthly payment of $13,300. The Company will also be billed for travel and other out-of-pocket costs, such as report production, postage, etc., if any. Ms. Lili Dai, age 47, joined GKC in December 2023 and currently chairs their consulting practice. Ms. Dai possesses a diverse background encompassing accounting, auditing, financial reporting, and management. Since August 2023, she has served as Interim VP Controller at Inno Holdings Inc. an

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing